Division of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Germany.
Division of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Germany.
Heart Rhythm. 2021 Dec;18(12):2040-2047. doi: 10.1016/j.hrthm.2021.08.011. Epub 2021 Aug 14.
Conduction disturbances after transcatheter aortic valve implantation (TAVI) are common, heterogeneous, and frequently result in permanent pacemaker implantation (PPI). Pacemaker therapy with a high rate of right ventricular pacing is associated with heart failure, hospitalizations, and reduced quality of life.
The purpose of this study was to compare medium-term outcomes between PPI implantation strategies, as choosing the right indication for PPI is still an area of uncertainty and information on outcomes of PPI regimens beyond 1 year is rare.
We compared outcomes after 3 years between a restrictive PPI strategy, in which the lowest threshold for PPI was left bundle branch block (LBBB) (QRS >120 ms) with the presence of new atrioventricular block (PQ >200 ms), and a liberal PPI regimen, in which PPI already was performed in patients with new-onset LBBB.
Between January 2014 and December 2016, TAVI was performed in 884 patients at our center. Of these, 383 consecutive, pacemaker-naive patients underwent TAVI with the liberal PPI strategy and subsequently 384 with the restrictive strategy. The restrictive strategy significantly reduced the percentage of patients undergoing PPI before discharge (17.2% vs 38.1%; P <.001). The incidence of the primary endpoint (all-cause-mortality and hospitalization for heart failure) after 3 years was similar in both groups (30.7% vs 35.2%; P = .242), as was all-cause-mortality (26.6% vs 29.2%; P = .718). Overall, patients who required PPI post-TAVI had significantly more hospitalizations due to heart failure (14.8% vs 7.8%; P = .004).
A restrictive PPI strategy after TAVI reduces PPI significantly and is safe in medium-term follow-up over 3 years.
经导管主动脉瓣植入(TAVI)后发生传导障碍较为常见,且具有异质性,通常需要植入永久性起搏器(PPI)。高比例右心室起搏的起搏器治疗与心力衰竭、住院和生活质量降低有关。
本研究旨在比较 PPI 植入策略的中期结果,因为选择 PPI 的正确适应证仍然存在不确定性,而且关于 PPI 方案超过 1 年的结果信息很少。
我们比较了 3 年后限制性 PPI 策略(最低 PPI 阈值为左束支传导阻滞(LBBB)(QRS > 120 ms)伴新发房室传导阻滞(PQ > 200 ms))与自由性 PPI 方案(LBBB 新发患者已植入 PPI)之间的 3 年后结果。
2014 年 1 月至 2016 年 12 月,我们中心对 884 例连续、无起搏器的 TAVI 患者进行了前瞻性研究。其中,383 例连续、无起搏器的 TAVI 患者采用自由性 PPI 策略,随后 384 例采用限制性策略。限制性策略显著降低了出院前 PPI 植入的患者比例(17.2% vs 38.1%;P <.001)。两组 3 年后主要终点(全因死亡率和心力衰竭住院)的发生率相似(30.7% vs 35.2%;P =.242),全因死亡率也相似(26.6% vs 29.2%;P =.718)。总体而言,TAVI 后需要 PPI 的患者因心力衰竭住院的比例显著更高(14.8% vs 7.8%;P =.004)。
TAVI 后采用限制性 PPI 策略可显著减少 PPI,且 3 年的中期随访是安全的。